Skip to content

A Phase 1 study to evaluate the effect of BV100 on the pharmacokinetics of polymyxin B in healthy volunteers

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521020-30-00
Enrollment
16
Registered
2026-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial. Intended indication: treatment of infections due to A. baumannii.

Interventions

None listed

Sponsors

Bioversys S.A.S.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Mar 2, 2026